<DOC>
	<DOC>NCT01903668</DOC>
	<brief_summary>Step 1: Identification and characterisation of the TREM1L protein from samples already available characterised at the hospital Central of Nancy Step 2: Study of the isoforms of TREM1L in correlation with the prognosis of sepsis, Step 3: implementation of assay methods for TREM1L (ELISA or SUPRA MS) Step 4: Validation of assays for TREM1L and its isoforms in a larger number of subjects (inclusion of samples from Dijon CHU and Besan√ßon CHU)</brief_summary>
	<brief_title>Determination of the Nature of the Endogenous Ligand of TREM-1 and Its Use as a New Diagnostic Biomarker in Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<criteria>patients hospitalised in a Medical Intensive Care unit whatever the reason written informed consent obtained patients less than 18 years old or under guardianship, persons without national health insurance.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>